CGON insider transaction filings
CG Oncology, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen CGON transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $74.54 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $71.17 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Mulay James — Director | Option exercise (M): 24,165 @ $26.63 · Sale (S): 24,165 @ $75.16 · Option exercise (M): 24,165 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Liu Brian Guan-Chyun — Director | Purchase (P): 371,085 @ $66.87 | EDGAR |
| 2026-06-25 | 4 | POST LEONARD E — Director | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $70 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | POST LEONARD E — Director | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $65 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Mulay James — Director | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $60.12 · Option exercise (M): 1,310 @ $12.59 · Sale (S): 1,310 @ $60.12 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Liu Brian Guan-Chyun — Director | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Tong Victor Edward Jr — Director | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Rossi Christina — Director | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Mulay James — Director | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Graf Susan E — Director | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $54.50 · Option exercise (M): 1,000 (derivative) @ $0 · Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | Mulay James — Director | Option exercise (M): 15,600 @ $36.63 · Sale (S): 15,600 @ $73.01 · Option exercise (M): 15,600 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Bellete Ambaw — President and COO | Grant/award (A): 107,508 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Kasturi Vijay — Chief Medical Officer | Grant/award (A): 79,216 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Kuan Arthur — Chief Executive Officer, Director | Grant/award (A): 271,600 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Patterson Joshua F. — See Remarks | Grant/award (A): 45,266 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | DETORE JAMES M. — Chief Financial Officer | Grant/award (A): 90,574 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Mulay James — Director | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $63.50 · Option exercise (M): 1,310 @ $12.59 · Sale (S): 1,310 @ $63.50 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Kuan Arthur — Chief Executive Officer, Director | Option exercise (M): 64,612 @ $1.72 · Tax withholding (F): 1,847 @ $60.15 · Option exercise (M): 64,612 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Kuan Arthur — Chief Executive Officer, Director | Option exercise (M): 102,871 @ $1.72 · Tax withholding (F): 2,871 @ $61.61 · Option exercise (M): 102,871 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Mulay James — Director | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $44.16 · Option exercise (M): 10,491 @ $12.59 · Sale (S): 10,491 @ $52.99 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 10,491 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Rossi Christina — Director | Grant/award (A): 20,889 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $41.43 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $43.25 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | Mulay James — Director | Option exercise (M): 5,903 @ $3.72 · Sale (S): 5,903 @ $43.99 · Option exercise (M): 5,903 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | POST LEONARD E — Director | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $40.09 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Mulay James — Director | Option exercise (M): 12,755 @ $1.82 · Sale (S): 12,755 @ $39.19 · Option exercise (M): 12,755 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Mulay James — Director | Option exercise (M): 19,112 @ $1.82 · Sale (S): 19,112 @ $39.01 · Option exercise (M): 3,574 @ $1.82 · Sale (S): 3,574 @ $38.99 · Option exercise (M): 19,112 (derivative) @ $0 · Option exercise (M): 3,574 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $35.10 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Liu Brian Guan-Chyun — Director | Purchase (P): 1,515,151 @ $33 | EDGAR |
| 2025-09-08 | 4 | Mulay James — Director | Option exercise (M): 27,015 @ $0.60 · Sale (S): 12,342 @ $30.47 · Sale (S): 4,095 @ $31.42 · Sale (S): 7,465 @ $32.64 · Sale (S): 3,113 @ $33.22 · Option exercise (M): 27,015 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Song Hong Fang — Director | Sale (S): 69,695 @ $27.60 · Sale (S): 30,105 @ $28.24 · Sale (S): 100 @ $28.96 · Sale (S): 100 @ $28.99 | EDGAR |
| 2025-09-04 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | POST LEONARD E — Director | Option exercise (M): 2,000 @ $0.60 · Sale (S): 2,000 @ $28 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Song Hong Fang — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Liu Brian Guan-Chyun — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Tong Victor Edward Jr — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Mulay James — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Graf Susan E — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | POST LEONARD E — Director | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $30.76 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Kuan Arthur — Chief Executive Officer, Director | Grant/award (A): 527,660 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Bellete Ambaw — President and COO | Grant/award (A): 284,816 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Kasturi Vijay — Chief Medical Officer | Grant/award (A): 203,868 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Roche Corleen M. — CFO | Grant/award (A): 143,907 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Patterson Joshua F. — See Remarks | Grant/award (A): 119,922 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | POST LEONARD E — Director | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CG Oncology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-27 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CGON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →